LT
IDXX icon

Legacy Trust’s Idexx Laboratories IDXX Stock Holding History

Legacy Trust’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$634K Buy
1,204
+8
+0.7% +$4.49K 0.11% 119
2026
Q1 		$672K Hold
1,196
– – 0.13% 111
2025
Q4 		$809K Hold
1,196
– – 0.15% 103
2025
Q3 		$764K Sell
1,196
-5
-0.4% -$3.04K 0.15% 104
2025
Q2 		$644K Sell
1,201
-5
-0.4% -$2.39K 0.16% 93
2025
Q1 		$506K Sell
1,206
-9
-0.7% -$3.91K 0.12% 105
2024
Q4 		$502K Sell
1,215
-9
-0.7% -$3.95K 0.12% 105
2024
Q3 		$618K Buy
1,224
+5
+0.4% +$2.43K 0.14% 100
2024
Q2 		$594K Hold
1,219
– – 0.15% 95
2024
Q1 		$658K Buy
1,219
+5
+0.4% +$2.73K 0.16% 93
2023
Q4 		$674K Buy
1,214
+1
+0.1% +$469 0.18% 89
2023
Q3 		$530K Buy
1,213
+2
+0.2% +$997 0.15% 96
2023
Q2 		$608K Sell
1,211
-4
-0.3% -$1.92K 0.17% 91
2023
Q1 		$608K Buy
1,215
+443
+57% +$212K 0.18% 90
2022
Q4 		$315K Buy
+772
New +$300K 0.1% 119

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Legacy Trust's IDXX Position: Q2 2026 in Review

Legacy Trust increased its Idexx Laboratories (IDXX) stake by 0.67% in Q2 2026, buying an estimated $4.49K and bringing the position to 1,204 shares worth $634K. The position accounts for 0.11% of the portfolio, ranked #119.

Legacy Trust first reported a position in IDXX in Q4 2022 and has held it in 15 quarters since. The position peaked at $809K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Legacy Trust held 1,204 shares of Idexx Laboratories worth $634K as of Q2 2026.
  • Legacy Trust bought 8 Idexx Laboratories shares in Q2 2026, an estimated $4.49K.
  • Idexx Laboratories made up 0.11% of Legacy Trust's portfolio in Q2 2026, its #119 holding.
  • Legacy Trust first reported a position in Idexx Laboratories in Q4 2022 and has held it in 15 quarters since.
  • Legacy Trust's Idexx Laboratories position peaked at $809K in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Legacy Trust's 13F filing for Q2 2026, filed 31 Jul 2026.